Indeed, as blockade of TNF has not shown consistent results in regulation of IR in human obesity [42–44], our findings may suggest probing potential roles for RAGE as a novel target for therapeutic intervention in obesity and its immunometabolic complications. This evidence concerns the gene TNF and obesity due to melanocortin 4 receptor deficiency.